UNMC participating in test of new COVID vaccine candidate
UNMC and its clinical partner, Nebraska Medicine, plan to enroll up to 1,000 people in the study of the COVID vaccine developed by the Maryland biotech firm Novavax Inc.
UNMC and its clinical partner, Nebraska Medicine, plan to enroll up to 1,000 people in the study of the COVID vaccine developed by the Maryland biotech firm Novavax Inc.